The largest database of trusted experimental protocols

Histone h3 antibody

Manufactured by Cell Signaling Technology
Sourced in United States

The Histone H3 antibody is a primary antibody that targets the histone H3 protein, which is a core component of nucleosomes in eukaryotic cells. This antibody can be used to detect and quantify the presence of histone H3 in various biological samples, such as cell lysates or tissue extracts, using techniques like Western blotting or immunohistochemistry.

Automatically generated - may contain errors

23 protocols using histone h3 antibody

1

Quercetin Modulation of Cell Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dulbecco’s modified Eagle’s media (DMEM), Dulbecco’s phosphate buffer saline (DPBS), fetal bovine serum (FBS), penicillin–streptomycin, quercetin dihydrate (Qu), 3-(4,5-dimetylthiazol-yl)-diphenyl tetrazolium bromide (MTT), propidium iodide, rhodamine 123, 2,7-dichlorodihydrofluoresceindiacetate (H2DCF-DA), Fluo-3 AM, proteinase K, ribonuclease A, 1,2-bis-(O-aminophenoxy)-ethane-N,N,N’,N’-tetraacetic acid, tetraacetoxymethyl ester (BAPTA-AM), β-nicotinamide adenine dinucleotide reduced disodium salt (β-NADH), ascorbic acid, agarose, dimethyl sulfoxide (DMSO) and anti-β-actin antibody were purchased from Sigma–Aldrich Chemicals (St. Louis, MO). Antibodies against Bcl-2, Bax, Bim, AIF, NF-κB, caspase-3/caspase-8, phospho-MEK, MEK1/2, phospho-ERK, ERK 1/2, phospho-p38, p-38, phospho-JNK, JNK, Nrf-2, catalase, Cu/Zn SOD, PI3K, phospho-Akt, Akt and GAPDH were purchased from Santa Cruz Biotechnology (Santa Cruz Biotechnology, Inc,). FITC Annexin V was purchased from BD Pharmingen. Histone H3 antibody was purchased from Cell Signaling Technology.
Stock solution of quercetin (Qu) was prepared in dimethyl sulfoxide (DMSO) and diluted to the desired final concentration with culture medium just before use. The final DMSO concentration did not exceed 0.1% (v/v).
+ Open protocol
+ Expand
2

Breast Cancer Cell Lines Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
ER- human breast non-tumorigenic epithelial cell lines (MCF-10A, MCF-10F and MCF-10-2A), ER+ human breast cancer cell lines (MCF-7 and T-47D) and ER- human breast cancer cell lines MDA-MB231 and SKBR-3) were from ATCC (Manassas, Virginia, USA). Tamoxifen was from Sigma-Aldrich. Cell culture medium (DMEM/F12), OPTI-MEM, Lipofectamine 2000 and TRIzol reagent were from Life Technologies (San Diego, CA, USA). Antibodies against β-actin and TFIIIC63 and c-Jun siRNA (Catalog No. SC-29224) were obtained from Santa Cruz Biotech (Santa Cruz, CA, USA). Mismatch RNA was described previously [24 (link)]. Histone H3 antibody were from Cell Signaling (Danvers, MA, USA). Brf1 antibody was from Bethyl laboratories Inc (Montgomery, TX, USA). The sequences of primers were described in (Supplements) [8 (link), 30 (link)].
+ Open protocol
+ Expand
3

Evaluating WEE1 and Phospho-cdc2 Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
The WEE1 and Phospho-cdc2 (Tyr15) expressions were examined by Western blotting. A nuclear protein and plasma protein extraction kit (Generay, Shanghai, China) was used to extract nuclear protein, which was separated using 11% polyacrylamide gel electrophoresis (SDS-PAGE), and transferred onto the top of the polyvinylidene fluoride (PVDF) membrane; PBS (PH 7.2) containing 6% dried skim milk was used to block at room temperate for 1–2 h; afterwards, the blocked PVDF membrane was placed in a freezer at 4°C overnight. Wee1 antibody and Tyr15 antibody (all at 1:500 dilution; Cell Signaling Technology) and Histone H3 antibody (at 1:1000 dilution; Cell Signaling Technology) were add as the primary antibody. After staying at room temperate for 1 h, it was washed with PBS, and human antibody against rabbit antibiotin-horseradish peroxidase (HRP) -IgG at 1:2500 dilution was added. At the same time, 40 μL of HRP antibodies at 1: 1000 dilution was added for reaction at room temperate for 1 h. Then, chemiluminescence reagent was added and immunoautoradiography was used to assess protein expressions.
+ Open protocol
+ Expand
4

ChIP Assay Protocol for ZBTB48 Binding

Check if the same lab product or an alternative is used in the 5 most similar protocols
ChIP assays were performed using the ChIP Assay Kit (Beyotime) according to the manufacturer’s instructions. Briefly, an anti-ZBTB48 antibody, Histone H3 antibody (Cell signaling technology) as a positive control and IgG antibody (Abcam) as a negative control were used to immunoprecipitate the chromatin complexes. Then DNA was extracted and purified from the complexes and analyzed by qPCR. The primers for ChIP qPCR are listed in Table S5.
+ Open protocol
+ Expand
5

Preparation of Nuclear Extracts from Liver Tissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
Nuclear extracts were prepared using a slight modification of the method described by Dignam, Lebovitz & Roeder (1983) (link). Briefly, samples of frozen liver tissue (∼1 g) were homogenized in 1 mL of homogenization buffer (10 mM HEPES, pH 7.9, 10 mM KCl, 10 mM EDTA) with the addition of 10 µL of 100 mM dithiothreitol (DTT) and 10 µL protease inhibitor cocktail. Samples were centrifuged at 10,000 rpm for 10 min at 4 °C and the supernatant (cytoplasmic extract) was removed. The pellet was resuspended in 147 µL of extraction buffer (20 mM HEPES, pH 7.9, 400 mM NaCl, 1 mM EDTA, 10% v:v glycerol) with 1.5 µL of 100 mM DTT and 1.5 µL of protease inhibitor cocktail added. The tubes were capped, put in ice on a rocking platform for 1 h, and then centrifuged at 10,000× g for 10 min at 4 °C. The supernatant (nuclear extract) was collected. The integrity of the nuclei was confirmed by immunoblotting of cytoplasmic and nuclear fractions and probing with a histone H3 antibody (Cell Signaling; Cat# 9715).
+ Open protocol
+ Expand
6

ChIP Assay Protocol Using SimpleChIP Kit

Check if the same lab product or an alternative is used in the 5 most similar protocols
ChIP assay was conducted by using the SimpleChIP Enzymatic Chromatin IP Kit (Cell Signaling Technology, USA) in accordance with the protocol formulated by the manufacturer. In brief, the cells were cross-linked with formaldehyde, lysed with sodium dodecyl sulfate buffer, and then sonicated. Following sonication, the fragmented chromatin was added into ChIP dilution buffer and incubated overnight with primary antibody. IgG antibody (Cell Signaling Technology) was taken as a negative control and Histone H3 antibody (Cell Signaling Technology) was taken as a positive control. Immunoprecipitation product was gathered following the incubation with ChIP-Grade Protein G Magnetic Beads (Cell Signaling Technology). After the binding chromatin was eluted and digested with Proteinase K (Cell Signaling Technology), the purified DNA was applied to conduct qRT-PCR assay. Supplemental Table S2 lists the antibodies used for ChIP and Supplementary Table S4 shows the sequences of forward and reverse primers used for ChIP.
+ Open protocol
+ Expand
7

Chromatin Immunoprecipitation (ChIP) of MEIS1

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chromatin immunoprecipitation (ChIP) was performed using the SimpleChIP® Plus Enzymatic Chromatin IP Kit (Magnetic Beads) (Cell Signaling #9005). Briefly, 12 × 106 cells were collected and fixed with 1.5% of fresh formaldehyde, incubated for 10 min at 20 °C, and stopped with 125 mM glycine for 5 min at 4 °C. Next, the SimpleChIP® Plus Enzymatic Chromatin IP protocol was followed. The Adaptive Focused Acoustics™ (AFA) Technology from Covaris (Waltham, MA, USA) was used to sonicate chromatin for 4 min with 5% of sonication (75 Watts) two times. Chromatin was precleared with protein G agarose beads (Cell Signaling Technology, Waltham, MA, USA) for 2 h at 4 °C and immunoprecipitated with 8.5 μL of MEIS1-specific antibodies (Atlas Antibodies HPA056000), a negative control IgG antibody, or a positive control Histone H3 antibody (Cell Signaling Technology) overnight at 4 °C.
PCRs were performed in triplicate using the HotStarTaq Master Mix (QIAGEN), and the primer sequences used are listed in Table S5.
All immunoprecipitations were carried out in triplicate, using different chromatin preparations.
+ Open protocol
+ Expand
8

ChIP Assay for Hepatocyte Chromatin

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chromatin was prepared from hepatocytes for ChIP assays as previously described. Cells were fixed with 4% paraformaldehyde for 15 min, then glycine was added to a final concentration of 0.125 M and incubated for 10 min before harvesting. Chromatin was sonicated using a Bioruptor Pico instrument (Diagenode, Denville, NJ, USA). Chromatin preparations were subjected to ChIP using a ChIP-IT High Sensitivity Kit and Protein G Agarose Prepacked Columns (Active Motif, Carlsbad, CA, USA) using a PPARα (Abcam Ab24509) antibody. Normal rabbit IgG (Cell Signaling Technologies #2729S) and Histone H3 antibody (Cell Signaling Technologies #4620) were used as negative and positive controls, respectively. DNA was purified and concentrated using MinElute Reaction Cleanup columns (Qiagen). qRT-PCR and conventional PCR were performed using 2 μl of ChIP DNA samples from the 50 μl of purified samples using gene-specific primers (Table S1). Cycle threshold (Ct) values of ChIP and input samples were calculated and presented as fold change values.
+ Open protocol
+ Expand
9

Evaluating Tazemetostat Effects on EZH2

Check if the same lab product or an alternative is used in the 5 most similar protocols
At the end of the tazemetostat treatment, we collected fresh tumors and peripheral blood mononuclear cells (PBMC) to assess the efficacy of the drug on EZH2 activity. PBMCs were exposed to RBC lysis buffer (NH4Cl: 155 mM; NaHCO3: 10 mM; EDTA: 0.1 mM) for 5 min on ice and washed with MACS buffer twice to remove red blood cells. Subsequently, PBMC were labeled with Aqua dead (L34966A; Invitrogen) for 30 min at 4 °C in PBS and subsequently fixed with fixation/permeabilization buffer (Ref: 00-5223-56, Invitrogen) during 30 min at 4 °C. Afterward, cells were intracellularly labeled with histone H3 antibody (ref: 12230S; Cell Signaling) and the specific H3K27me3 antibody (reference: 5499S) for 30 min at 4 °C in permeabilization buffer (Ref: 00-8333-56, Invitrogen). Finally, cells were washed and resuspended in MACs buffer for FACS analysis in BD LSR Fortessa. Gates were defined on single and live cells and the signal of H3K27me3 staining was calculated as a ratio of total H3 staining. In parallel, freshly resected tumors were fixed in formol/ethanol, and then embedded in paraffin; H3K27me3 staining was assessed using the tri-methyl-histone H3 (Lys27) (C36B11) with the previously described procedure. Brain delivery was not evaluated considering the extradural bone origin of chordomas.
+ Open protocol
+ Expand
10

Cytoplasmic and Nuclear Protein Extraction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Nuclear and cytoplasmic extracts were made according to previously published protocols (Smith et al., 2004 (link); Rozenfeld and Devi, 2007 (link)). Briefly, PANC-1 cells were treated with 10 nM dermorphin or 10 nM (1R,1′S,3′R/1R,1′R,3′S)-L-054,264 (Tocris, Bristol, UK) individually and in combination for the indicated times. After the treatment, cells were washed in ice-cold PBS three times and scraped into lysis buffer (10 mM Tris, pH 7.4, 10 mM NaCl, 3 mM MgCl2, 1 mM ethylene glycol tetraacetic acid, 1 mM sodium orthovanadate, and a protease phosphatase inhibitor tablet [ThermoFisher Pierce]) and incubated on ice for 10 min. The lysate was then homogenized and centrifuged at 375 × g for 5 min. The pellet consisting of the nuclear fraction was washed five times with lysis buffer containing 0.1% NP-40 to remove any nonnuclear contamination and resuspended in lysis buffer containing NP-40. The soluble fraction was centrifuged twice at 375 × g to remove nuclear contamination and used as the cytosolic fraction. Fractions were then used for immunoblotting for anti–phospho-ERK1/2, anti–phospho-p90RSK (Thr-573; rabbit polyclonal; Cell Signaling, Danvers, MA), and anti–β-actin as a loading control for the cytoplasmic fraction, and Histone H3 antibody (rabbit monoclonal; Cell Signaling) was used as a loading control for the nuclear fraction.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!